Inflammation  >>  NN9828  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NN9828 / Almirall
NCT01647451 / 2011-005376-42: A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis

Checkmark ACR-ARHP 2014: Rheumatoid Arthritis
Oct 2014 - Oct 2014: ACR-ARHP 2014: Rheumatoid Arthritis
Completed
2
62
Europe, RoW
NNC0114-0006, placebo
Novo Nordisk A/S
Inflammation, Rheumatoid Arthritis
08/13
08/13
NCT01751152 / 2012-002432-93: A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

Completed
2
53
US, Europe
NNC0114-0006, placebo
Novo Nordisk A/S
Inflammation, Crohn's Disease
12/14
12/14

Download Options